Firas Eladoumikdachi named program director at Rutgers Cancer Institute of New Jersey at Hamilton

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

FIRAS ELADOUMIKDACHI was named program director for the Rutgers Cancer Institute of New Jersey at Hamilton. He will be responsible for clinical leadership of the oncology service line at RWJ Hamilton including medical, surgical and radiation oncology.

Eladoumikdachi is an assistant professor of surgery at Rutgers Robert Wood Johnson Medical School. He has been with RWJ Hamilton and the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute in New Brunswick for the past year. Prior to that, Eladoumikdachi served as the director of the breast program at Genesis Health Care System in Ohio and vice chair of Ohio Integrated Care Providers.

YOU MAY BE INTERESTED IN

By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it.  To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...

As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease.  The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login